SARS-CoV-2 Variant-Specific mRNA Vaccine: Pros and Cons-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SARS-CoV-2 Variant-Specific mRNA Vaccine: Pros and Cons

Published:2023-02-16 Issue: Volume: Page:
ISSN:0882-8245
Container-title:Viral Immunology
language:en
Short-container-title:Viral Immunology

Author:

Shahsavandi Shahla¹^ORCID,Hariri Amir Ali²³

Affiliation:

1. Razi Vaccine and Serum Research Institute, Agricultural Research Education and Extension Organization, Karaj, Iran.

2. Biotechnology Department, Bahyaar Sanaat Sepahan Company, Isfahan, Iran.

3. Pharmaceutical Biotechnology, School of Pharmacy and Pharmaceutical Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.

Publisher

Mary Ann Liebert Inc

Subject

Virology,Molecular Medicine,Immunology

Link

https://www.liebertpub.com/doi/pdf/10.1089/vim.2022.0121

Reference35 articles.

1. Covid-19 Vaccine Effectiveness against the Omicron (B.1.1.529) Variant

2. Increased transmissibility and global spread of SARS-CoV-2 variants of concern as at June 2021

3. Serological evidence of human infection with SARS-CoV-2: a systematic review and meta-analysis

4. In silico analyses on the comparative sensing of SARS‐CoV‐2 mRNA by the intracellular TLRs of humans

5. Molecular Aspects of Spike–ACE2 Interaction

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP